Oral Session

Oral Session 3-10D MPN: Clinical (2)

Sun. Oct 14, 2018 3:00 PM - 4:00 PM No.10 (Osaka International Convention Center, 10F 1009)

Chair: Keita Kirito (Department of Hematology and Oncology, Japan)

+Add all to schedule

[OS3-10D-1] Anagrelide platelet-lowering effect correlated with increase of mean platelet volume

Naohiro Miyashita¹, Masahiro Onozawa¹, Koji Hayasaka², Takanori Teshima¹ (1.Hematol., Hokkaido Univ., Sapporo, Japan, 2.Division of Laboratory and Transfusion Medicine, Hokkaido Univ., Sapporo, Japan)

[OS3-10D-2] Interferon therapy for pregnant patients with myeloproliferative neoplasms

Yoko Edahiro¹, Akihiko Gotoh¹, Jun Ando¹, Miyuki Tsutsui¹, Soji Morishita², Akimichi Ohsaka², Norio Komatsu¹ (1.Department of Hematology, Juntendo University, 2.Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University)

[OS3-10D-3] Cytoreductive therapy prevents worsening of renal function in patients with primary myelofibrosis

Yasutaka Fukuda¹, Marito Araki², Kouji Yamamoto³, Soji Morishita², Tadaaki Inano¹, Kyohei Misawa¹, Tomonori Ochiai¹, Yoko Edahiro¹, Misa Imai^1,4, Akihiko Gotoh¹, Akimichi Ohsaka², Norio Komatsu¹ (1.Hematology, Juntendo Univ., Tokyo, Japan, 2.Transfusion Medicine and Stem Cell Regulation, Juntendo Univ., Tokyo, Japan, 3.Medical Statistics, Osaka City Univ., Osaka, Japan, 4.Lead. Cent. Dev. Res. Cencer Med., Juntendo Univ., Tokyo, Japan)

[OS3-10D-4] Clinical features of essential thrombocythemia in Miyazaki

Ayako Kamiunten¹, Yuki Tahira¹, Keiichi Akizuki¹, Masaaki Sekine¹, Takuro Kameda¹, Kotaro Shide¹, Tomonori Hidaka¹, Yoko Kubuki¹, Kiyoshi Yamashita², Takanori Toyama³, Kouichi Maeda⁴, Hiroshi Kawano⁵, Masanori Takeuchi⁵, Hitoshi Matsuoka⁵, Junzo Ishizaki⁶, Kazuya Shimoda¹ (1.Department of Hematology,Faculity of Medicine, University of Miyazaki, 2.Miyazaki Prefectural Miyazaki Hospital, 3.Miyazaki Prefectural Nobeoka Hospital, 4.Miyakonojo Medical Center, 5.KOGA GENERAL HOSPITAL, 6.Miyazaki Aisenkai Nichinan hospital)

[OS3-10D-5] Retrospective analysis of essential thrombocythemia in a single institute

Rie Ito, Daisuke Koyama, Naoto Imoto, Shingo Kurahashi, Isamu Sugiura (Department of Hematology and Oncology, Toyohashi Municipal Hospital, Aichi, Japan)

[OS3-10D-6] Efficacy and safety assessment of anagrelide alone and in combination with hydroxycarbamide in ET

Yasunobu Sekiguchi¹, Hiroko Iizuka¹, Haruko Takizawa¹, Mutsumi Wakabayashi¹, Keiji Sugimoto¹, Sakura Sakajiri¹, Miyuki Tsutsui², Tomohiro Sawada³, Mitsuo Okubo⁴, Norio Komatsu², Masaaki Noguchi¹ (1.Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan, 2.Department of Hematology, Juntendo University Hospital,Tokyo, Japan, 3.Clinical Laboratory, Juntendo University Urayasu Hospital, Chiba, Japan, 4.Department of Blood Transfusion, Juntendo University Urayasu Hospital, Chiba, Japan)